B-cell lymphoma

The causes of diffuse large B-cell lymphoma are not well understood.

It is a form of immunotherapy that can be used only among people who have developed a B-cell lymphoma.

All the cases were classified as B-cell lymphomas with a complete immunophenotype.

For children with diffuse large B-cell lymphomas, most studies have found 5-year survival rates ranging from about 70% to more than 90%.

Can also be primary mediastinal B-cell lymphoma with exceptionally good prognosis.

Still, about half the patients with diffuse large B-cell lymphoma die and half are cured, he said.

Diffuse large B-cell lymphoma is the most common of the large-cell lymphomas.

For example, scientists have made specific proteins known as monoclonal antibodies to fight each patient's B-cell lymphoma.

Recurrent mutations in this gene have been associated to cases of diffuse large B-cell lymphoma.

Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma.

The B-cell lymphomas are types of lymphoma affecting B cells.

Seliciclib is also in clinical trials for B-cell lymphomas, including multiple myeloma.

He has B-cell lymphoma, now in remission.

Mistargeted somatic hypermutation is a likely mechanism in the development of B-cell lymphomas.

Approximately 70 percent are B-cell lymphoma.

It is similar to diffuse large B-cell lymphoma; however, it generally has a significantly better prognosis.

He had reeled through the shock of learning that he had cancer, a B-cell lymphoma.

Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type.

It was diagnosed as a diffuse large B-cell lymphoma, an intermediate grade type, but her chances of being cured were up to 90%.

Mediastinal large B-cell lymphoma is a form of lymphoma involving the mediastinum.

Scott is battling B-cell lymphoma and is battling depression.

Many other B-cell lymphomas feature large cells:

Early in 2010, Van Wieren was diagnosed with cutaneous B-cell lymphoma.

Its high transcriptional activity has been observed in the testes, thymus, and diffuse B-cell lymphomas.

Camp was diagnosed with non-Hodgkins large B-cell lymphoma in 2012, said to be in the early stages of growth.